Skip to Content

'
Vikas Kundra, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Director Molecular Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1995 Harvard Medical School, Harvard University, Boston, MA, MD, with Honors in a Special Field, Medicine
1995 Harvard Medical School, Harvard University, Boston, MA, PHD, with Honors in a Special Field, Program in Cell and Developmental Biology

Board Certifications

2000 The American Board of Radiology

Experience/Service

Academic Appointments

Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007-2012

Administrative Appointments/Responsibilities

Section Chief, Body Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010-2012

Honors and Awards

2009-present Fellow, Society of Computed Body Tomography/Magnetic Resonance (SCBT/MR)
2004 Who's Who in Executives and Professionals, National Register
2000 Brigham and Women's Hospital Annual Research Award for Outstanding Research by a Radiology Resident, Department of Radiology, Harvard Medical School
2000 Dodd Research Award, Society of Gastrointestinal Radiology
1997 Brigham and Women's Hospital Annual Research Award for Outstanding Research by a Radiology Resident, Department of Radiology, Harvard Medical School
1997 CREF Research Award
1997 Introduction to Research Program, Radiologic Society of North America
1997 Mallinkrodt Research Fellowship/Grant, Society of Nuclear Medicine
1995 M.D. with Honors, Harvard Medical School
1993 Proctor and Gamble Professional Opportunity Award for Outstanding Abstract in Cell and General Physiology, American Physiological Society
1987-1988 Fulbright Scholarship to the United Kingdom
1987 Summer Scientist Training, National Institutes of Health
1986 Biology Honor Society, Beta-Beta-Beta
1986 Jesuit Honor Society, Alpha-Sigma-Nu
1986 Outstanding Achievement in Organic Chemistry Award
1986 Who's Who in American Universities
1984-1987 Presidential Scholarship II, Loyola College

Selected Publications

Peer-Reviewed Original Research Articles

1. Ganeshan D, Bhosale P, Yang T, Kundra V. Imaging features of carcinoid tumors of the gastrointestinal tract. AJR Am J Roentgenol 201(4):773-86, 10/2013. PMID: 24059366.
2. Ganeshan D, Morani A, Ladha H, Bathala T, Kang H, Gupta S, Lalwani N, Kundra V. Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT. Abdom Imaging. e-Pub 9/28/2013. PMID: 24077815.
3. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 4:2427, 9/2013. PMID: 24018975.
4. Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL, Ma J. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: Clinical utility per sequence. Magn Reson Imaging 31(5). e-Pub 1/2013. PMID: 23290478.
5. Ravoori MK, Han L, Singh SP, Dixon K, Duggal J, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V. Correction: Noninvasive Assessment of Gene Transfer and Expression by In Vivo Functional and Morphologic Imaging in a Rabbit Tumor Model. PLoS One 8(10), 2013. e-Pub 10/4/2013. PMCID: PMC3792172.
6. Ravoori MK, Han L, Singh SP, Dixon K, Duggal J, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V. Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model. PLoS One 8(6):e62371, 2013. e-Pub 6/2013. PMCID: PMC3677885.
7. Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V. Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging 12(0):1-10, 2013. PMID: 23962694.
8. Ravoori M, Duggal J, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V. Visualizing the prostate gland by MR imaging in young and old mice. PLoS One 8(3):e55746, 2013. e-Pub 3/2013. PMCID: PMC3585879.
9. Ganeshan D, Bhosale P, Kundra V. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know. AJR Am J Roentgenol 199(6):1283-93, 12/2012. PMID: 23169720.
10. Tan CH, Wei W, Johnson V, Kundra V. Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 199(4):822-9, 10/2012. PMID: 22997374.
11. Bhosale P, Shah A, Wei W, Varadhachary G, Johnson V, Shah V, Kundra V. Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur Radiol. e-Pub 8/2012. PMID: 22932740.
12. Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC, Mills GB. Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol 126(1):47-53, 7/2012. e-Pub 4/2012. PMID: 22487539.
13. Ng CS, Waterton JC, Kundra V, Brammer D, Ravoori M, Han L, Wei W, Klumpp S, Johnson VE, Jackson EF. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat 11(3):279-88, 6/2012. e-Pub 3/2012. PMID: 22417064.
14. Costelloe CM, Kundra V, Ma J, Chasen BA, Rohren EM, Bassett RL, Madewell JE. Fast dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging 35(2):399-408, 2/2012. e-Pub 10/2011. PMCID: PMC3265627.
15. Le O, Roy A, Silverman PM, Kundra V. Common and uncommon adult unilateral renal masses other than renal cell carcinoma. Cancer Imaging 12:194-204, 2012. e-Pub 5/2012. PMID: 22752221.
16. Roy A, Le O, Silverman PM, Kundra V. Common and uncommon bilateral adult renal masses. Cancer Imaging 12:205-11, 2012. e-Pub 5/2012. PMID: 22750134.
17. Wan X, Li ZG, Yingling JM, Yang J, Starbuck MW, Ravoori MK, Kundra V, Vazquez E, Navone NM. Effect of transforming growth factor beta (TGF-ß) receptor I kinase inhibitor on prostate cancer bone growth. Bone. e-Pub 12/2011. PMID: 22173053.
18. Coleman RL, Duska LR, Ramirez PT, Heymach JV, Kamat AA, Modesitt SC, Schmeler KM, Iyer RB, Garcia ME, Miller DL, Jackson EF, Ng CS, Kundra V, Jaffe R, Sood AK. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol 12(12):1109-1117, 11/2011. PMID: 21992853.
19. Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, Cheng KW, Hall H, Zhang D, Lu Y, Ravoori M, Kundra V, Ajani JA, Lee JS, Hong WK, Mills GB. Dual inhibition of tumor energy pathway by 2-deoxy glucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther 10(12). e-Pub 10/2011. PMID: 21992792.
20. Gupta S, Wright KC, Ensor J, Van Pelt CS, Dixon KA, Kundra V. Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model. Cardiovasc Intervent Radiol 34(5):1021-30, 10/2011. PMID: 21479746.
21. Tamm EP, Rong XJ, Cody DD, Ernst RD, Fitzgerald NE, Kundra V. Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality. Radiographics 31(7). e-Pub 10/2011. PMID: 21969662.
22. Perin EC, Tian M, Marini FC, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One 6(9):e22949, 9/2011. PMCID: PMC3164664.
23. Wright KC, Ravoori MK, Dixon KA, Han L, Singh SP, Liu P, Gupta S, Johnson VE, Kan Z, Kundra V. Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model. Radiology 260(3):718-26, 9/2011. PMCID: PMC3157000.
24. Harris DM, Hazan-Haley I, Coombes K, Bueso-Ramos C, Liu J, Liu Z, Li P, Ravoori M, Abruzzo L, Han L, Singh S, Sun M, Kundra V, Kurzrock R, Estrov Z. Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One 6(6):e21250, 6/2011. PMCID: PMC3120836.
25. Bhosale P, Kwek JW, Iyer R, Wei W, Bassett R, Kundra V. Follow-up of known carcinoid liver metastases: Is respiratory-gated T2 fast spin-echo enough? Neuroendocrinology 93(4):241-248, 4/2011. PMID: 21474918.
26. Tan CH, Wang J, Kundra V. Diffusion weighted imaging in prostate cancer. Eur Radiol 21(3):593-603, 3/2011. PMID: 20936413.
27. Singh SP, Han L, Murali R, Solis L, Roth J, Ji L, Wistuba I, Kundra V. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model. Hum Gene Ther 22(1):55-64, 1/2011. PMCID: PMC3025187.
28. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK. Regulation of tumor angiogenesis by EZH2. Cancer Cell 18(2):185-197, 8/2010. PMCID: PMC2923653.
29. Le-Petross H, Kundra V, Szklaruk J, Wei W, Hortobagyi GN, Ma J. Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging 31(4):889-894, 2010. PMID: 20373433.
30. Ravoori M, Czaplinska AJ, Sikes C, Han L, Johnson EM, Qiao W, Ng C, Cody DD, Murphy WA, Do KA, Navone NM, Kundra V. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One 5(3):e9854, 2010. PMCID: PMC2847943.
31. Ma J, Costelloe CM, Madewell JE, Hortobagyi GN, Green MC, Cao G, Sun F, Kundra V. Fast Dixon-based multi-sequence and multi-planar MRI for whole body detection of cancer metastases. J Magn Reson Imaging 29(5):1154-1162, 2009. PMID: 19388121.
32. Singh SP, Yang D, Ravoori M, Han L, Kundra V. In vivo functional and anatomic imaging for assessment of in vivo gene transfer. Radiology 252(3):763-771, 2009. PMID: 19587310.
33. Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One 4(10):e7628, 2009. PMCID: PMC2764087.
34. Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clin Cancer Res 15(6):2130-2139, 2009. PMID: 19276258.
35. Rampurwala M, Ravoori MK, Wei W, Johnson VE, Vikram R, Kundra V. Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer. Transl Oncol 2(2):96-106, 2009. PMCID: PMC2670577.
36. Garlich JR, De P, Dey N, Su JD, Peng X, Miller A, Murali R, Lu Y, Mills GB, Kundra V, Shu HK, Peng Q, Durden DL. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity (Kundra lab images on the journal cover page). Cancer Res 68(1):206-215, 2008. PMID: 18172313.
37. Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 118(8):2697-2710, 2008. PMCID: PMC2447924.
38. Bankson JA, Ji L, Ravoori M, Han L, Kundra V. Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer. J Magn Reson Imaging 27(1):57-62, 2008. PMID: 18058933.
39. Han L, Yang D, Kundra V. Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging 6(6):427-437, Nov-Dec, 11/2007. PMID: 18053413.
40. Kim TJ, Ravoori M, Landen CN, Kamat AA, Han LY, Lu C, Lin YG, Merritt WM, Jennings N, Spannuth WA, Langley R, Gershenson DM, Coleman RL, Sood AK, Kundra V. Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res 67(19):9337-9345, 10/2007. PMID: 17909042.
41. Ramirez MS, Ragan DK, Kundra V, Bankson JA. Feasibility of multiple-mouse dynamic contrast-enhanced MRI. Magn Reson Med 58(3):610-615, 2007. PMID: 17763350.
42. Auzenne E, Ghosh SC, Khodadadian M, Rivera B, Farquhar D, Price RE, Ravoori M, Kundra V, Freedman RS, Klostergaard J. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 9(6):479-486, 2007. PMCID: PMC1899257.
43. Kundra V, Silverman PM, Matin SF, Choi H. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol 189(4):830-844, 2007. PMID: 17885053.
44. Kundra V, Ng CS, Ma J, Bankson JA, Price RE, Cody DD, Do KA, Han L, Navone NM. In vivo imaging of prostate cancer involving bone in a mouse model. Prostate 67(1):50-60, 2007. PMID: 17031813.
45. Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Pharmacodynamic markers of perifosine efficacy. Clin Cancer Res 13(24):7421-7431, 2007. PMID: 18094426.
46. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12(8):939-944, 2006. e-Pub 7/2006. PMID: 16862152.
47. Sood A, Lu C, Jennings N, Armaiz-Pena G, Bankson J, Ravoori M, Merritt W, Lin Y, Mangala S, Tae JK, Coleman R, Landen C, Li Y, Felix E, Newman R, Lloyd M, Gershenson D, Kundra V, Lopez-Bernstein G, Cole S, Arevalo J, Takahashi R, Lutgendorf S. Stress and the spread of ovarian cancer in mice. Cancer Biol Ther 5(8):893-896, 2006.
48. Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, Kundra V, Ji L. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells (Kundra lab images on the journal cover page). Cancer Res 66(19):9682-9690, 2006. PMID: 17018626.
49. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9(3):225-238, 2006. PMID: 16530706.
50. Yang D, Han L, Kundra V. Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology 235(3):950-958, 2005. PMID: 15914480.
51. Kundra V, Krane JF, Nikolaidis P, Green DS, Zou KH, Tuncali K, Vansonnenberg E, Silverman SG. Telomerase activity predicts malignancy in percutaneous image-guided needle biopsy specimens of the abdomen and pelvis. Radiology 234(3):941-947, 2005. PMID: 15734943.
52. Kundra V, Silverman PM. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol 180(4):1045-1054, 2003. PMID: 12646453.
53. Kundra V, Silverman PM. Impact of multislice CT on imaging of acute abdominal disease. Radiol Clin North Am 41(6):1083-1093, 2003. PMID: 14661659.
54. Kundra V, Mannting F, Jones AG, Kassis AI. Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med 43(3):406-412, 2002. PMID: 11884502.
55. Blatch GL, Lassle M, Zetter BR, Kundra V. Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif. Gene 194(2):277-282, 1997. PMID: 9272871.
56. Lassle M, Blatch GL, Kundra V, Takatori T, Zetter BR. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J Biol Chem 272(3):1876-1884, 1997. PMID: 8999875.
57. Kundra V, Anand-Apte B, Feig LA, Zetter BR. The chemotactic response to PDGF-BB: evidence of a role for Ras. J Cell Biol 130(3):725-731, 1995. PMCID: PMC2120528.
58. Kundra V, Stoker S, Zetter BR. Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB. Oncogene 9(5):1429-1435, 1994. PMID: 8152804.
59. Yenush L, Kundra V, White MF, Zetter BR. Functional domains of the insulin receptor responsible for chemotactic signaling. J Biol Chem 269(1):100-104, 1994. PMID: 8276780.
60. Kundra V, Zetter BR. Molecular mechanisms of metastasis. Intern and Staff Physician, 1994.
61. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Williams LT, Zetter BR. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367(6462):474-476, 1994. PMID: 8107807.
62. Kundra V, Dean MF. Transformed SV3T3 cells have a reduced lysosomal compartment and lower levels of enzyme activity than 3T3 cells. Exp Cell Res 189(1):93-99, 1990. PMID: 1693341.

Invited Articles

1. Kundra V. Prostate cancer imaging. Semin Roentgenol 41(2):139-149, 2006. PMID: 16697892.
2. Kundra V. Testicular cancer. Semin Roentgenol 39(3):437-450, 2004. PMID: 15372756.

Book Chapters

1. Kundra V, Matin SF, Kuban DA. Prostate cancer. In: Oncologic Imaging, A Multidisciplinary Approach. Elsevier Saunders, 2012.
2. Kundra V. Clinical potential of gene expression imaging. In: Molecular Imaging in Oncology. Ed(s) M Pomper, J Gelovani. Informa Press: New York, 429-442, 2008. ISBN: 0849374170.
3. Kundra V, Mawlawi O. PET imaging in genomic medicine. In: Genomic and Personalized Medicine. Ed(s) H Willard, G Ginsburg. Elsevier: Amsterdam; Boston, 461-469, 2008.
4. Kundra V, Schellingerhout D, Jackson EF. Targeted and functional imaging. In: Targeted Cancer Therapy. Ed(s) R Kurzrock, M Markman. Humana Press: Totowa, 335-360, 2008. ISBN: 978-1-60327-423-4.
5. Channock SJ, Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 5th. Ed(s) PA Pizzo, DG Poplack. Lippincott Williams & Wilkins: Philadelphia, 1446-1465, 2006.
6. Channock SJ, Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 4th. Ed(s) PA Pizzo, DG Poplack. Lippincott Williams & Wilkins: Philadelphia, 1393-1410, 2002.
7. Channock SJ, Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 3rd. Ed(s) PA Pizzo, DG Poplack. Lippincott-Raven: Philadelphia, 1157-1169, 1997.
8. Channock SJ,Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 2nd. Ed(s) PA Pizzo, DG Poplack. J.B. Lippincott: Philadelphia, 1157-1169, 1993.

Grant & Contract Support

Title: In vivo Metabolic Imaging of Renal Cell Carcinoma
Funding Source: UT MD Anderson Cancer Center Kidney Cancer Research Program
Role: Principal Investigator
Duration: 4/1/2013 - 3/31/2014
 
Title: Imaging Stem Cells In Vivo
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 9/1/2012 - 8/31/2017
 
Title: Long Term Tracking of Stem Cells
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 4/1/2012 - 3/31/2017
 
Title: Clinical Translation of Therapeutic siRNA in Solid Malignancies
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Co-Investigator
Principal Investigator: Coleman R
Duration: 12/1/2011 - 11/30/2014
 
Title: Virus-resembling optical nano-materials for ovarian cancer imaging and phototherapy
Funding Source: National Science Foundation (NSF)
Role: Co-Principal Investigator
Duration: 8/1/2011 - 7/31/2014
 
Title: Clinically Practical Whole Body MRI of Prostate Cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: J Ma
Duration: 7/1/2011 - 6/30/2016
 
Title: Simultaneous Multiple-Animal SPECT Imaging
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Y Shao
Duration: 7/1/2011 - 6/30/2014
 
Title: Personalizing Nanoparticle Therapy
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 3/1/2011 - 2/29/2016
 
Title: Molecular Theragnostics of Ovarian Cancer
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: A Sood
Duration: 1/1/2011 - 1/1/2016
 
Title: The University of Texas M.D. Anderson Cancer Center SPORE in Ovarian Cancer: Targeting D114-Notch Signaling in Ovarian Cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: R Bast
Duration: 9/15/2010 - 8/31/2015
 
Title: Targeting DII4-Notch Signaling in Ovarian Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Duration: 9/1/2010 - 11/30/2005
 
Title: Chemopreventive Effect of Fish Oil Derived EPA in Lung Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: P Yang
Duration: 7/1/2010 - 4/30/2014
 
Title: Imaging the prostate gland and otrhotopic prostate cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Logothetis C
Duration: 12/1/2009 - 12/31/2013
 
Title: MD Anderson Cancer Center Prostate SPORE
Funding Source: NIH/NCI
Role: Project Leader
Principal Investigator: C Logothetis
Duration: 9/2/2009 - 12/31/2013
 
Title: Image Based Evaluation of Tumor Targeting and Efficacy of Gene Therapy
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 1/15/2009 - 12/31/2012
 
Title: Stem Cell Engraftment
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 2009 - 2014
 
Title: UPRCCC/MDACC Partnership for Excellence in Cancer Research: Synthesis and Pre-clincal Evaluation of Targeted, Iron-Based MRI Contrast Agents to Enhance Ovarian Cancer Detection and Treatment Scheduling
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: R DuBois
Duration: 9/29/2008 - 8/31/2013
 
Title: Sweet Gum Extract and Late Stage Prostate Cancer
Funding Source: NIH
Role: Collaborator
Principal Investigator: P Yang
Duration: 9/15/2008 - 6/30/2011
 
Title: Molecular Theragnostics of Ovarian Cancer
Funding Source: NIH
Role: Project Leader
Principal Investigator: A Sood
Duration: 2008 - 2013
 
Title: Prostate Cancer Models Linking Molecular Signature to Clinical Stage and Therapeutic Response
Funding Source: Prostate Cancer Foundation
Role: Collaborator
Principal Investigator: N Navone
Duration: 2008 - 2011
 
Title: Nanoparticles for Treatment of Lung Cancer
Funding Source: NIH, SBIR
Role: Collaborator
Principal Investigator: S Chada
Duration: 2008 - 2010
 
Title: Image-Guided Delivery and Image-Guided Evaluation of Target and Non-Target Tissue
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 8/30/2007 - 8/31/2011
 
Title: Tumor and PTK-Targeted Therapy by FUS1 and PTK Inhibitors
Funding Source: NIH
Role: Collaborator
Principal Investigator: L Ji
Duration: 5/1/2007 - 4/30/2012
 
Title: Following DNA Vaccine Expression and T-Cell Trafficking to Lymphoma
Funding Source: UT-MDACC Center for Targeted Therapy (CTT) Disease-Specific Grant Program
Role: Principal Investigator
Duration: 2007 - 2009
 
Title: Objective Evaluation of DCE-CT and DCE-MRI in Assessing Tumor Perfusion and Permeability Changes with AZ Drugs in the Angiogenesis Biological Effect Area in an Animal Model
Funding Source: AstraZeneca
Role: Collaborator
Principal Investigator: R Bast
Duration: 10/5/2006 - 7/1/2010
 
Title: Alliance of Nanohealth Seed Grant Projects - DOD: On-Command Control of Blood Pool Residence Time for Nanoparticle-Based Molecular Imaging
Funding Source: University of Texas Health Science Center - Houston
Role: Project Leader
Principal Investigator: R Bast
Duration: 9/29/2006 - 10/28/2009
 
Title: Medical Physics Training Grant for Image-Guided Therapy Research
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: EF Jackson
Duration: 8/4/2006 - 7/31/2012
 
Title: Whole Body MRI for Detecting Breast Cancer Metastases
Funding Source: Susan G. Komen Breast Cancer Foundation
Role: Collaborator
Principal Investigator: J Ma
Duration: 5/1/2006 - 4/30/2009
 
Title: SPORE in Ovarian Cancer: Imaging Ovarian Cancer Specific Gene Expression In Vivo
Funding Source: NIH/NCI
Role: Project Leader
Principal Investigator: R Bast
Duration: 3/16/2006 - 8/31/2010
 
Title: The University of Texas M.D. Anderson Cancer Center SPORE in Prostate Cancer: Imaging the Natural History of Prostate Cancer Involving Bone in a Mouse Model
Funding Source: NIH/NCI
Role: Program Leader
Principal Investigator: C Logothetis
Duration: 6/1/2005 - 12/31/2007
 
Title: Identification and Validation of Methods to Determine Delivery of Biologically Relevant Dose of Perifosine to Patient Tumors
Funding Source: Keryx
Role: Co-Investigator
Principal Investigator: G Mills
Duration: 12/31/2004 - 12/31/2006
 
Title: Identification and Validation of Methods to Determine Delivery of Biologically Relevant Dose of LY317615 and Its Metabolite LY492403 to Patient Tumors
Funding Source: Ely Lilly and Company
Role: Co-Investigator
Principal Investigator: G Mills
Duration: 12/17/2004 - 12/16/2006
 
Title: Preclinical Studies to Translate SSTR2A Reporter Imaging for Assessing Gene Transfer into Lung Tumors
Funding Source: The University of Texas Southwest Medical Center
Role: Co-Investigator
Principal Investigator: JD Minna
Duration: 2004 - 2005
 
Title: Antivascular Therapy of Ovarian Carcinoma
Funding Source: Aventis Pharmaceuticals Products
Role: Co-Investigator
Principal Investigator: AK Sood
Duration: 2004 - 2005
 
Title: Bone Marrow Stem Cells as a Source of Hepatocytes
Funding Source: US Department of Energy
Role: Principal Investigator
Duration: 8/1/2003 - 12/31/2007
 
Title: Non-Invasive Imaging of Gene Transfer into Pancreatic Tumor Cells In Vivo
Funding Source: Topfer Fund for Pancreatic Cancer Research
Role: Principal Investigator-MDACC
Duration: 2002 - 2004
 
Title: Noninvasive Imaging of Pancreatic Tumor Apoptosis using Radiolabeled PEGylated Annexin V and Diffusion-Weighted Magnetic Resonance Imaging
Funding Source: Topfer Fund for Pancreatic Cancer Research
Role: Principal Investigator-MDACC
Duration: 2002 - 2004
 
Title: Visualizing Prostate Cancer Metastasis to Bone in Mouse Models
Funding Source: The University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program
Role: Study Chairman
Duration: 2002 - 2003
 
Title: Telomerase Activity in Needle Biopsy Specimens
Funding Source: Society of Gastrointestinal Radiology, Wylie J. Dodds Research Award
Role: Collaborator
Principal Investigator: SG Silverman
Duration: 2000 - 2001
 
Funding Source: Brigham and Women's Hospital
Role: Investigator
Duration: 1995 - 2001
 
Title: Designer Imaging Checking TIL
Funding Source: NIH/NCI
Role: Principal Investigator
 
Title: Nanoparticle Guidance for Diagnosing and Surgically Removing Ovarian Cancer
Funding Source: Mike Hogg
Role: Principal Investigator
 
Title: Optical imaging and phototherapy of fallopian tube and ovarian cancers
Funding Source: National Science Foundation (NSF)
Role: Co-Principal Investigator

Last updated: 12/11/2013